skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Pharmacokinetics of o-nitroanisole in Fischer 344 rats

Journal Article · · Drug Metab. Dispos.; (United States)
OSTI ID:6232425

The pharmacokinetics and metabolism of o-nitroanisole (ONA) were studied in male Fischer 344 rats. Three dose levels of ( UC)ONA (5.0, 50, or 500 mg/kg) were administered orally to rats and daily excreta were analyzed for UC. Since the highest dose altered the urinary excretion rate of ONA, a dose of 25 mg/kg was used for subsequent pharmacokinetic studies. Following a single 25 mg/kg iv dose of ( UC)ONA, blood, tissues, and excreta were collected at times ranging from 15 min to 7 days. Urinary excretion accounted for 82% of the dose by 24 hr and 86% by 7 days. Fecal excretion was 7.5% in 24 hr and 9.0% by 7 days. Fifteen min after ONA administration, most of the UC content was found in muscle (20%), skin (10%), adipose tissue (6.8%), and blood (6.5%). The initial elimination t1/2 for UC in all tissues was 1-2 hr and the terminal t1/2 was approximately 4 days. The elimination of parent ONA from blood followed first order biphasic elimination kinetics. Parent ONA was rapidly eliminated from all other tissues in a monophasic manner. Skin and fat demonstrated an uptake phase prior to the elimination of parent. Only 0.5% of the dose was excreted as ONA in the urine. Urinary metabolites of ONA were predominantly conjugated compounds.

Research Organization:
Univ. of Arizona, Tucson
OSTI ID:
6232425
Journal Information:
Drug Metab. Dispos.; (United States), Vol. 5
Country of Publication:
United States
Language:
English